Xu LY - Search Results

1

Tongguanteng injection exerts anti-osteosarcoma effects through the ER stress-associated IRE1/CHOP pathway.

Xue XC, Zhou YY, Xu LY, Wei LY, Hu YJ, Yang J, Zhang XQ, Wang MY, Han YL, Chen JJ. Xue XC, et al. Among authors: xu ly. BMC Complement Med Ther. 2024 Nov 16;24(1):400. doi: 10.1186/s12906-024-04689-7. BMC Complement Med Ther. 2024. PMID: 39550552 Free PMC article.

2

P-glycoprotein-mediated herb-drug interaction evaluation between Tenacissoside G and paclitaxel.

Hu J, Hu Y, Xu L, Chen J, Shi M, Wu W, Yang J, Han Y. Hu J, et al. Biomed Chromatogr. 2024 Oct;38(10):e5984. doi: 10.1002/bmc.5984. Epub 2024 Aug 17. Biomed Chromatogr. 2024. PMID: 39152775

3

[Research progress on the effect of tumor-associated macrophages on breast cancer and its targeted therapy].

Zhao J, Chen J, Zhou Y, Xu L, Wang X, Han Y. Zhao J, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 Nov;40(11):1035-1043. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024. PMID: 39566531 Review. Chinese.

4

Study on Cytochrome P450 Metabolic Profile of Paclitaxel on Rats using QTOF-MS.

Meng Z, Chen J, Xu L, Xiao X, Zong L, Han Y, Jiang B. Meng Z, et al. Curr Drug Metab. 2024;25(5):330-339. doi: 10.2174/0113892002308509240711100502. Curr Drug Metab. 2024. PMID: 39039675

5

Gallic acid: a dietary metabolite's therapeutic potential in the management of atherosclerotic cardiovascular disease.

Zhao XL, Cao ZJ, Li KD, Tang F, Xu LY, Zhang JN, Liu D, Peng C, Ao H. Zhao XL, et al. Among authors: xu ly. Front Pharmacol. 2025 Jan 7;15:1515172. doi: 10.3389/fphar.2024.1515172. eCollection 2024. Front Pharmacol. 2025. PMID: 39840111 Free PMC article. Review.

6

Inhibitory effects of Valeriana fauriei root extract on serotonin uptake in vitro caused by the interaction among its active ingredients including a new compound.

Ota M, Maki Y, Xu LY, Oiwa Y, Sekiguchi M, Makino T. Ota M, et al. Among authors: xu ly. J Ethnopharmacol. 2025 Jan 18:119374. doi: 10.1016/j.jep.2025.119374. Online ahead of print. J Ethnopharmacol. 2025. PMID: 39832628

7

Covalent Inhibitor Screening for Targeting LOXL2: Studied by Virtual Screening and Experimental Validation.

Lin L, Lin K, Chen L, Wang Y, Xu LY, Li EM, Liu Q, Zou H, Dong G. Lin L, et al. Among authors: xu ly. Recent Pat Anticancer Drug Discov. 2025 Jan 2. doi: 10.2174/0115748928356643241216132041. Online ahead of print. Recent Pat Anticancer Drug Discov. 2025. PMID: 39757678

8

Comparative accuracy assessment of analog and virtual wax-up in prosthetic-driven planning and guided implant surgery: A retrospective cohort study.

Zhou WT, Du XJ, Luo ZL, Xu LY, Cao YG, Song K. Zhou WT, et al. Among authors: xu ly. J Prosthodont Res. 2025 Jan 4. doi: 10.2186/jpr.JPR_D_24_00053. Online ahead of print. J Prosthodont Res. 2025. PMID: 39756937 Free article.

9

Tunable band alignment and large power conversion efficiency in a two-dimensional InS/ZnIn₂S₄ heterostructure.

Liu HY, Lin HF, Xu LY, Hou TP, Liu NS. Liu HY, et al. Among authors: xu ly. RSC Adv. 2024 Dec 23;14(54):40077-40085. doi: 10.1039/d4ra06901c. eCollection 2024 Dec 17. RSC Adv. 2024. PMID: 39717804 Free PMC article.

10

NIR-715 photodynamic therapy induces immunogenic cancer cell death by enhancing the endoplasmic reticulum stress response.

Zheng ZY, Lin W, Su JW, Huang QF, Zhang C, Pan WX, Li EM, Zhang HF, Xu LY. Zheng ZY, et al. Among authors: xu ly. Cell Death Dis. 2024 Dec 18;15(12):890. doi: 10.1038/s41419-024-07283-4. Cell Death Dis. 2024. PMID: 39695072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters